U.S. Chemicals Stock News

Bank OZK recently announced that its Board of Directors raised the quarterly cash dividend on common stock to US$0.47 per share and declared a quarterly dividend of US$0.28906 per share on its 4.625% Series A Non-Cumulative Perpetual Preferred Stock, both payable in mid-April and mid-May 2026 to shareholders of record. This latest dividend increase extends Bank OZK’s long record of dividend growth and may be read as a signal of management’s confidence in the bank’s underlying financial...

Goodyear Tire & Rubber (NasdaqGS:GT) moved to second place in JD Power's 2026 luxury tire segment rankings. Michelin reclaimed the top spot in the luxury category, which Goodyear had led in the 2025 survey. The shift highlights changing customer perceptions in a high-margin part of the tire market. Goodyear, a global tire manufacturer with a broad footprint across consumer and commercial segments, now sits behind Michelin in JD Power's luxury tire rankings for 2026. Luxury tires are often...

Archer Aviation (NYSE:ACHR) announced that Chief Administrative Officer Tosha Perkins will move into a senior advisor role. The transition shifts Perkins from an executive leadership position to an advisory capacity within the company. For investors tracking Archer Aviation, the leadership change comes as the stock trades at $5.21, with a 30.7% decline over the past month and a 35.9% decline year to date. Over the past year, the share price shows a 27.6% decline, while the three year return...

Over the last 7 days, the United States market has remained flat, but it is up 16% over the past year with earnings expected to grow by 15% per annum over the next few years. In this environment, identifying high growth tech stocks involves looking for companies with strong innovation capabilities and robust business models that can capitalize on these favorable market conditions.

In the last week, the United States market has remained flat, yet over the past 12 months it has experienced a notable rise of 16%, with earnings projected to grow by 15% annually. In this environment, identifying stocks that are potentially undervalued can offer opportunities for investors seeking to capitalize on assets priced below their estimated fair value.

The United States market remained flat over the last week but has seen a 16% increase over the past year, with earnings forecasted to grow by 15% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and may be well-positioned for substantial revenue growth.

Over the last 7 days, the market has remained flat, but it is up 16% over the past year with earnings forecast to grow by 15% annually. In light of these conditions, identifying stocks with strong financials and a clear growth trajectory can be beneficial. While "penny stocks" might seem like an outdated term, they still represent smaller or less-established companies that could offer significant value.

Over the last 7 days, the United States market has remained flat, yet it boasts an impressive 16% growth over the past year, with earnings expected to increase by 15% annually in the coming years. In this promising environment, identifying stocks that are not only resilient but also poised for growth can uncover hidden opportunities within a dynamic and evolving landscape.

The United States market has remained flat over the last week, though it has seen a 16% increase over the past year with earnings projected to grow by 15% annually. In such a dynamic environment, identifying standout dividend stocks involves finding companies that not only offer consistent payouts but also have the potential for growth in line with broader market expectations.

Toast (TOST) is back in focus after recent analyst estimate revisions highlighted expectations for a meaningful EPS improvement. This has prompted investors to reassess how its restaurant platform and enterprise wins might influence the stock. See our latest analysis for Toast. Despite the optimism around earnings and new enterprise wins, Toast’s share price return has been weak recently. The 30 day share price return is 5.44% and the 90 day share price return is 26.58%, while the 3 year...

Vodafone Idea’s decision to modernize its transport network with Ciena (CIEN) WaveLogic 6 Extreme coherent optical technology, including 1.6 Tb/s data center links in India, has put fresh focus on the stock’s role in AI era bandwidth demand. See our latest analysis for Ciena. That Vodafone Idea win lands at a time when Ciena’s share price has climbed 77.6% over the past 90 days and 68.8% year to date, while the 1 year total shareholder return is well over 5x. This points to strong momentum as...

On March 31, 2026, MINISO Group Holding reported record fourth-quarter and full-year 2025 revenue growth but a sharp drop in profitability, completed a HK$632.51 million share buyback totaling 19,003,004 shares, and declared a final ordinary dividend of US$0.0941 per share for 2025 alongside an amended dividend policy targeting about 50% of adjusted net profit. The combination of strong sales momentum, increased impairments and weaker earnings, together with ongoing capital returns through...

Investors may be considering whether Cadence Design Systems at around US$280 per share still aligns with its underlying worth, or if expectations have run ahead of reality. The stock closed at US$280.19, with returns of a 0.4% decline over 7 days, 7.6% decline over 30 days, 9.7% decline year to date, 5.8% gain over 1 year, 35.0% gain over 3 years and 96.5% gain over 5 years. This presents a mixed picture of recent and longer-term performance. Recent news coverage has focused on Cadence...

What Teva’s latest biosimilar milestones mean for investors Teva Pharmaceutical Industries (NYSE:TEVA) has just reported three key milestones in its biosimilar portfolio, including US Food and Drug Administration approval for PONLIMSI as a biosimilar to Prolia and regulatory progress on a proposed Xolair biosimilar. These product updates sit alongside a mixed share price backdrop, with the stock showing a 0.4% return over the past day and 2.7% over the past week, as well as declines over the...

Pathward Financial (CASH) has drawn investor attention after recent share price moves, with the stock showing mixed short term returns and a stronger pattern over the past 3 months and year to date. See our latest analysis for Pathward Financial. The recent move to a share price of $90.02 comes after a 26.79% 90 day share price return and a 25.25% year to date share price return. The 3 year total shareholder return of 120.58% points to a stronger longer term trend. If you are comparing...

Globalstar stock snapshot after recent price move Globalstar (GSAT) has drawn fresh attention after a recent daily gain of about 3.2%, adding to its month and past 3 months returns. That move invites a closer look at its current fundamentals. See our latest analysis for Globalstar. Beyond the latest move, Globalstar’s 30 day share price return of 10.53% and 90 day share price return of 12.27% sit alongside a very large 1 year total shareholder return, suggesting momentum has been building...

Wondering if Insmed's current share price lines up with its underlying worth, or if the recent excitement has moved it away from fair value? The stock recently closed at US$164.86, with returns of 11.7% over 7 days, 12.1% over 30 days, a 6.9% decline year to date, and very large gains over 1 year and 3 years that may change how you think about risk and reward. Recent headlines have focused on Insmed's progress as a biotech player, with attention on its pipeline developments and regulatory...

In late March 2026, Zoetis Inc. participated in the World Vaccine Congress in Washington, while also scheduling a May webcast and call to review its first-quarter 2026 financial results with investors. A separate development saw Bristol Gate Capital Partners exit its long-held Zoetis position, citing slowing dividend growth, setbacks for key osteoarthritis drug Librela, and rising competitive pressures in core product categories. Against this backdrop, we’ll now examine how concerns over...

If you are wondering whether Palantir Technologies is still priced for big expectations or has already run too far, the next sections focus squarely on what the current share price might imply about value. The stock last closed at US$146.49, after a 5.5% decline over the past week, a 0.9% gain over the past month, a 12.7% decline year to date, and a 67.5% return over the past year, with a very large gain over three and five years. Recent coverage has continued to focus on Palantir's role in...

Century Aluminum (CENX) is back in focus after a series of supply shocks in the global aluminum market and company specific moves, including a new Oklahoma smelter joint venture and recent asset reshuffling. See our latest analysis for Century Aluminum. The recent surge in Century Aluminum’s share price, including a 26.54% 7 day share price return and a very large 3 year total shareholder return, reflects rising interest after supply disruptions, Oklahoma smelter plans, and upgraded outlooks...

If you are wondering whether Adient's current share price gives you genuine value or just noise, starting with how the market has treated the stock recently can offer useful clues. Adient has seen a 2.8% decline over the past week and an 11.7% decline over the past month, although the shares are still up 9.4% year to date and 62.5% over the last year, with longer 3 year and 5 year returns of 45.7% and 50.5% declines respectively. These moves sit against an evergreen backdrop where investors...

Frontline plc recently confirmed that Director Richard C. Prince resigned from the board, as the company also released its audited 2025 annual report outlining performance and governance developments. At the same time, heightened tensions in the Middle East are disrupting key oil shipping lanes, tightening tanker supply and lifting charter rates for operators of Very Large Crude Carriers such as Frontline. We’ll now examine how tighter tanker availability amid Middle East tensions could...

KalVista Pharmaceuticals (KALV) is back in focus after releasing interim KONFIDENT-KID data on EKTERLY, its oral hereditary angioedema treatment for children, showing effective on demand use and a favorable tolerability profile. See our latest analysis for KalVista Pharmaceuticals. The KONFIDENT-KID update lands after a busy stretch for KalVista, with earnings in late March showing an eight month net loss of US$109.52 million and the share price now at US$19.77. This is supported by a 30 day...

If you are wondering whether Allegro MicroSystems at around US$33.30 still offers value or is starting to look expensive, you are in the right place. The stock has returned 2.1% over the last 7 days, while the 30 day return is a 9.0% decline, with longer term figures of 23.7% year to date, 28.5% over 1 year, 27.0% over 3 years and 21.4% over 5 years. Recent moves in Allegro MicroSystems' share price sit against a backdrop of ongoing interest in semiconductor names and shifting expectations...